Behavioral sensitization to nicotine is associated with behavioral disinhibition; counteraction by citalopram

Psychopharmacology

Volumn 142, Issue 2, 1999, Pages 111-119

  Olausson, Peter ^a   Engel, Jörgen A ^a   Söderpalm, Bo ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Behavioral sensitization; Citalopram; Elevated plus maze; Locomotor activity; Nicotine; Serotonin

Indexed keywords

CITALOPRAM; NICOTINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CITALOPRAM; DRUG INTERACTIONS; MALE; MAZE LEARNING; MOTOR ACTIVITY; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032937222     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050869     Document Type: Article

References (84)

1. Arnt J, Fredricson Overø K, Hyttel J, Olsen R (1984) Changes in rat dopamine and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 84:457-465
2. Balfour DJ, Graham CA, Vale AL (1986) Studies on the possible role of brain 5-HT systems and adrenocortical activity in behavioural responses to nicotine and diazepam in an elevated X-maze. Psychopharmacology 90:528-532
3. Balldin J, Berggren U, Engel J, Eriksson M, Hard E, Söderpalm B (1994) Effect of citalopram on alcohol intake in heavy drinkers. Alcohol Clin Exp Res 18:1133-1136
4. Benwell ME, Balfour DJ (1992) The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849-856
5. Benwell ME, Balfour DJ, Khadra LF (1994) Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine. Clin Invest 72:233-239
6. Benwell ME, Balfour DJ, Birrell CE (1995) Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br J Pharmacol 114: 454-460
7. Blier P, Chaput Y, de Montigny C (1988) Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 337:246-254
8. 1A receptor agonists reduce ethanol-induced locomotor activity in mice. Alcohol 11:157-161
9. Blomqvist O, Ericson M, Johnson DH, Engel JA, Söderpalm B (1996) Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol 314:257-267
10. Breese GR, Cooper BR, Mueller RA (1974) Evidence for the involvement of 5-hydroxytryptamine in the actions of amphetamine. Br J Pharmacol 52:307-314
11. Briley M, Chopin P, Moret C (1990) Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology 101:187-189
12. Brioni JD, O'Neill AB, Kim DJ, Decker MW (1993) Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plusmaze test. Eur J Pharmacol 238:1-8
13. Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4-methylene-dioxymethamphetamine in rats. J Pharmacol Exp Ther 254:456-464
14. Chen N-H, Reith MEA (1994) Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J Neurochem 63:1701-1713
15. Clarke PB, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358
16. Cunningham KA, Paris JM, Goeders NE (1992) Serotonin neurotransmission in cocaine sensitization. In: Kalivas PW, Samson HH (eds) The neurobiology of drug and alcohol addiction. The New York Academy of Sciences, New York, pp 117-127
17. Damsma G, Day J, Fibiger HC (1989) Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol 168:363-368
18. 1A antagonist WAY 100635 attenuates cocaine-induced hyperactivity, but not behavioral sensitization. Soc Neurosci Abstr 22:931
19. de Montigny C, Chaput Y, Blier P (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51 [Suppl B]:4-8
20. Decker MW, Anderson DJ, Brioni JD, Donnelly RD, Kang CH, O'Neill AB, Piattoni KM, Swanson S, Sullivan JP (1995) Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 280:79-89
21. Engel JA (1977) Neurochemical aspects of the euphoria induced by dependence-producing drugs. In: Ideström CM (ed) Recent advances in the study of alcoholism. Excerpta Medica, Amsterdam, pp 16-22
22. Engel JA, Liljequist S (1976) The effect of long-term ethanol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens. Psychopharmacology 49:253-257
23. Engel JA, Enerback C, Fahlke C, Hulthe P, Hård E, Johannessen K, Svensson B, Söderpalm B (1992) Serotonergic and dopaminergic involvement in ethanol intake. In: Naranjo CA, Sellers EM (eds) Novel pharmacological interventions for alcoholism. Springer, New York, pp 68-82
24. 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J Pharmacol Exp Ther 278:752-762
25. Grenhoff J, Aston-Jones G, Svensson TH (1986) Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:351-358
26. Guan X-M, McBride WJ (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 23:541-547
27. Gundlah C, Hjorth S, Auerbach SB (1997) Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology 36:475-482
28. Harro J, Löfberg C, Pahkla R, Matto V, Rägo L, Oreland L, Allikmets I (1997) Different molecular forms of cholecystokinin and CCKB receptor binding in the rat brain after chronic antidepressant treatment. Naunyn-Schmiedeberg's Arch Pharmacol 355:57-63
29. Hervé D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435:71-83
30. Hjorth S, Auerbach SB (1994) Lack of 5-HT1a autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33:331-334
31. Hjorth S, Westlin D, Bengtsson HJ (1997) Way 100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1a (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology 36:461-465
32. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6:65-70
33. Horger BA, Giles MK, Schenk S (1992) Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology 107:271-276
34. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1:19-26
35. Hyttel J, Fredricson Overø K, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83: 20-27
36. Ichikawa J, Meltzer HY (1992) Amperozide, a novel antipsychotic drug, inhibits the ability to increase dopamine in vivo in rat striatum and nucleus accumbens. J Neurochem 58:2285-2291
37. Invernizzi R, Bramante M, Samanin R (1994) Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1a receptors. Eur J Pharmacol 260:243-246
38. Johnson DH, Blomqvist JA, Engel JA, Söderpalm B (1995a) Subchronic intermittent nicotine treatment enhances ethanol-induced locomotor stimulation and dopamine turnover in mice. Behav Pharmacol 6:203-207
39. Johnson DH, Svensson AI, Engel JA, Söderpalm B (1995b) Induction but not expression of behavioural sensitization to nicotine in the rat is dependent on glucocorticoids. Eur J Pharmacol 276:155-164
40. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244
41. Kalivas PW, Sorg BA, Hooks MS (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334
42. Kirch DG, Gerhardt GA, Shelton RC, Freedman R, Wyatt RJ (1987) Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. Clin Neuropharmacol 10:376-383
43. Koob GF (1992) Neural mechanisms of drug reinforcement. In: Kalivas PW, Samson HH (eds) The neurobiology of drug and alcohol addiction. The New York Academy of Sciences, New York, pp 171-191
44. 3H]acetylcholine to nicotinic receptors. Neuropharmacology 24:527-532
45. LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 36:326-337
46. Mabry PD, Campbell BA (1973) Serotonergic inhibition of catecholamine-induced behavioral arousal. Brain Res 49: 381-391
47. Mifsud J-C, Hernandez L, Hoebel BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365-367
48. Moret C, Briley M (1996) Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur J Pharmacol 295:189-197
49. Naranjo CA, Sellers EM (1989) Serotonin reuptake inhibitors attenuates ethanol intake in problem drinkers. Rec Dev Alc 7: 255-266
50. Nestler EJ (1994) Molecular neurobiology of drug addiction. Neuropsychopharmacology 11:77-87
51. Nisell M, Nomikos GG, Svensson TH (1994a) Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 75:348-352
52. Nisell M, Nomikos GG, Svensson TH (1994b) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:36-44
53. Nisell M, Nomikos GG, Hertel P, Panagis G, Svensson TH (1996) Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 22:369-381
54. Olausson P, Ericson M, Petersson A, Kosowski A, Söderpalm B, Engel JA (1998) Nefazodone attenuates the behavioral and neurochemical effects of ethanol. Alcohol 15:77-86
55. 3 mediated control of dopaminergic function. Psychopharmacology 112:60-67
56. 3H]5-hydroxytryptamine. Neuroscience 6:115-138
57. Parsons LH, Justice JJ (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606:195-199
58. Pellow S (1986) Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Methods Find Exp Clin Pharmacol 8:557-565
59. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167
60. Piazza PV, Deminiere JM, le Moal M, Simon H (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514:22-26
61. Pierce RC, Kalivas PW (1995) Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther 275:1019-1129
62. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216
63. Post RM, Rose H (1976) Increasing effects of repetitive cocaine administration in the rat. Nature 260:731-732
64. Poulos C, Le A, Parker J (1995) Impulsivity predicts individual susceptibility to high levels of alcohol self-administration. Behav Pharmacol 6:810-814
65. Roberts DC, Loh EA, Baker GB, Vickers G (1994) Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol Biochem Behav 49:177-182
66. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
67. Rosenberg C, Damsbo N, Fuglum E, Jacobsen LV, Horsgard S (1994) Citalopram and imipramin in the treatment of depressive patients in general practice. A Nordic multicenter clinical study. Int Clin Psychopharmacol 9 [Suppl] 1:41-48
68. Roy A, Linnoila M (1988) Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand 78:529-535
69. Segal DS, Mandell AJ (1974) Long-term administration of d-amphetamine : progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249-255
70. Sellers EM, Naranjo CA, Kadlec K (1987) Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers. J Clin Psychopharmacol 7:417-420
71. Shoaib M, Benwell ME, Akbar MT, Stolerman IP, Balfour DJ (1994) Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br J Pharmacol 111: 1073-1080
72. Söderpalm B (1990) On the neuropharmacology of conflict behavior. Thesis, Göteborg University, Sweden
73. Söderpalm B, Engel JA (1990) Serotonergic involvement in conflict behaviour. Eur Neuropsychopharmacol 1:7-13
74. Söderpalm B, Svensson AI, Andersson G, Billig H, Engel JE (1996) Naloxone reverses disinhibitory/aggressive behavior and synaptic hypoactivity of 5-HT deficient rats. Soc Neurosci Abstr 22:1137
75. Soubrié P (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 9:319-364
76. Stein DJ, Trestman RL, Mitropoulou V, Coccaro EF, Hollander E, Siever LJ (1996) Impulsivity and serotonergic function in compulsive personality disorder. J Neuropsychiatr Clin Neurosci 8:393-398
77. Steinbusch HWM (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6:557-618
78. Suemaru K, Gomita Y, Furuno K, Araki Y (1993) Chronic nicotine treatment potentiates behavioral responses to dopaminergjc drugs in rats. Pharmacol Biochem Behav 46:135-139
79. Svensson L, Engel JA, Hård E (1989) Effects of the 5-HT receptor agonist 8-OH-DPAT, on the ethanol preference in the rat. Alcohol 6:17-21
80. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98: 45-50
81. Vale AL, Balfour DJK (1987) The role of hippocampal 5-HT in the effects of nicotine on habituation to an X-maze. Eur J Pharmacol 141:313-317
82. Vale AL, Balfour DJK (1989) Aversive environmental stimuli as a factor in the psychostimulant response to nicotine. Pharmacol Biochem Behav 32:857-860
83. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191-225
84. Wonnacott S, Drasdo A, Sanderson E, Rowell P (1990) Presynaptic nicotinic receptors and the modulation of transmitter release. In: Bock G, Marsh J (eds) The biology of nicotine dependence. Wiley, Chichester, pp 87-105